Formulation and Evaluation of Mefloquine Hydrochloride Nanoparticles
DOI:
https://doi.org/10.37285/ijpsn.2014.7.1.10Abstract
The present study deals with the formulation and evaluation of mefloquine hydrochloride nanoparticles. Mefloquine is a blood schizonticidal quinoline compound, which is indicated for the treatment of mild-to-moderate acute malarial infections caused by mefloquine-susceptible multi-resistant strains of P. falciparum and P. vivax. The purpose of the present work is to minimize the dosing frequency, taste masking toxicity and to improve the therapeutic efficacy by formulating mefloquine HCl nanoparticles. Mefloquine nanoparticles were formulated by emulsion diffusion method using polymer poly(ε-caprolactone) with six different formulations. Nanoparticles were characterized by determining its particle size, polydispersity index, drug entrapment efficiency, drug content, particle morphological character and drug release. The particle size ranged between 100 nm to 240 nm. Drug entrapment efficacy was >95%. The in-vitro release of nanoparticles were carried out which exhibited a sustained release of mefloquine HCl from nanoparticles up to 24 hrs. The results showed that nanoparticles can be a promising drug delivery system for sustained release of mefloquine HCl.
Downloads
Metrics
Keywords:
Mefloquine, Nanoparticles, Poly(ε-caprolactone), Emulsion diffusion, Zeta potential
Downloads
Published
How to Cite
Issue
Section
References
Allemann E, Gurny R and Doelker E(1993). Drug loaded nanoparticles- preparation methods and drug targeting issues. Eur J Pharm Biopharm 39: 173-191.
Couvreur P and Vauthier C (2006). Nanotechnology: intelligentdesign to treat complex disease. Pharm Res 23(7): 284-288.
Delphine Moinard-Checot, Chevalier Y, Riancon Stephanie, Benney Laurent and Hastem Fessi(2008). Mechanism of nanocapsules formulation by emulsion-diffusion process. J Colloidal and Interface Sci 317:458-468.
Dash Suvakanta, Murthy Padala Narasimha, NathLilakanta and Chowdhury Prasanta (2010). Kinetic Modeling on Drug Release from Controlled Drug Delivery Systems. Acta Poloniae Pharmaceutica-Drug Res 67(3): 219-220.
Gupta RB (2006). Fundamentals of drug nanoparticles. In: Gupta R B, Kompella U B. ed. Nanoparticles technology for drug delivery. Taylor & Francis Group, New York. 17(162): 2-6.
Hixson AW and Crowell JH (1931). Pharmaceutical technology. Ind. Eng. Chem. 23:923.
Jelvehgari M., Barar J., Valizadeh H., Delf Loveymi B. and Ziapour M (2010). Preparation of Diclofenac Sodium Composite Microparticles with Improved Initial Release Property. Transaction F: Nanotechnology 17(2):79-89.
Kasim NA, Whitehouse M, Ramachandran C, Bermejo M, Lennernas H, Hussain AS, Junginger HE, Stavchansky SA,Midha KK, Shah VP and Amidon GL(2004). Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Mol Pharm1:85-96.
Kreuter J (1994).Nanoparticles in Colloidal Drug Delivery Systems. New York, Marcel Dekker Inc: 9nd: 219-220.
K. Satish Kumar D. Gnanaprakash, K. Mayilvaganan, C. Arunraj and S. Mohankumar (2012). Chitosan-Gold Nanoparticles As Delivery Systems For Curcumin. IJPSR 3(11): 4537-4538.
Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA(1983). Int J Pharm 15:25.
Lindenberg M, Kopp S and Dressman JB (2004). Classification of orally administered drugs on the World Health Organization Model List of Essential Medicines according to the biopharmaceutics classification system. Eur J Pharm Biopharm 58: 265-278.
Mohanraj V J and Chen Y (2006). Nanoparticles-a review. Trop J Pharm Res. 5: 561-573.
Nidhin M, Indumathy R, Sreeram KJ and Balachandran U (2008). Synthesis of iron oxide nanoparticles of narrow size distribution on polysaccharide templates. Bull Mater Sci 3:93-96.
Pignatello R, Ricupero N, Bucolo, Maugeri F Maltese A and Puglisi G (2006).Preparation and characterization of eudragit retard nanosuspensions for the ocular delivery of cloricromene. AAPS Pharma Sci Tech 24(7):E27.
Shafiq-un-Nabi Sheikh, Faiyaz Shakeel, Talegaonkar Sushma, Ali Javed, Baboota Sanjula, Ahuja Alka., Khar Roop Kand Ali Mushir (2007). Formulation Development and Optimization Using Nanoemulsion Technique: A Technical Note. AAPS Pharm Sci Tech 8(2) Article 28.
Thassu D, Pathak Y, and Deleers M (2007). Nanoparticulate drug delivery systems: an overview. In: Thassu D, Deleers M, Pathak Y. eds. New York, 166: 188-190.
